GEA's wide range of container blenders offers the most flexible and highest quality blending solutions available today.
Container blending is recognised as being the most cost-effective and productive method of blending granules and powders in the pharmaceutical manufacturing process. Reduced loading and unloading times, reduced cleaning times — both machinery and room — improved containment and batch integrity have established container (IBC) blending as the pharmaceutical industry’s technology of choice.
R&D, small-scale and full-scale pharmaceutical production blenders provide simple transfer of process technology during scale-up, thus minimizing process validation activity.
This is fully supported by GEA's detailed research programme and testing facilities. Hoist- and pedestal-mounted versions are available as well as through-the-wall designs, which offer significant room layout benefits.
Alternative proteins are promising – yet still expensive to produce. The usual response is that scaling up will solve this issue. But what if the solution was really about getting better, not just bigger? From more efficient, high-yield processes to upcycling waste heat, engineers are reshaping how we grow food.
As anti-cancer drugs become more powerful and complex, GEA is redefining how to safely freeze-dry these life-saving treatments.
Digital transformation at GEA means more than new tools – it’s about bold ideas, customer impact and a culture that values and drives innovation. Meet this year’s GEA Better World Awards Innovation & Digitalization winners who were celebrated for solutions which are shaping the future of our business.